The type and dosage of radiation therapy is tailored to each patient and their specific type of cancer. A doctor that specializes in the treatment of cancer is called a radiation oncologist.

It is important to try and live as normal as
possible. Some people find it helpful to set short term goals while
having treatment. This helps break down the treatment
into achievable steps and gives you a sense of
moving forward.

Do the things you would normally do and
maintain reasonable physical fitness and activity.
It is important you maintain a good, varied diet.
Tell your doctor and pharmacist about any other
medication, pills or drugs that you’re taking.

You may find it helpful to try relaxation or meditation
techniques that can help you cope with side-effects.
The techniques can help you lower
any anxiety you may be feeling and help you approach
treatment with a more relaxed and positive attitude. The
physiotherapist and/or occupational therapist at your
hospital or local community health centre may be able
to assist you with this.
Assist your health team by keeping your appointments.
If you are unwell, or think you are unable to attend
an appointment, contact the health team as early as
possible. Try to have blood and other tests ordered at
the requested time. This may save you waiting longer for
results.
Keep up fluids at least two liters a day.
This helps the body get
rid of unwanted cells during treatment and is especially
important in the Queensland summer. Carry a water
bottle at all times.
Assist your health team by keeping your appointments.
If you are unwell, or think you are unable to attend
an appointment, contact the health team as early as
possible. Try to have blood and other tests ordered at
the requested time. This may save you waiting longer for
results.

Normal Cells

During the early stages of life, normal cells multiply faster to aid in the growth and development of the human body. In adulthood, normal cells only multiply to replace dying or worn-out cells and repair bodily injuries. Eventually, normal cells stop growing and die.

Cancer Cells

Cancer cells continue to grow, multiply uncontrollably and live longer. Uncontrollable cell growth may develop into a lump called a tumour. A tumour falls into two categories. A benign or noncancerous tumour does not multiply beyond its normal boundary. Malignant or cancerous cells grow outside the original boundary, and can destroy normal cells and harm healthy tissue. Cancer spreads when abnormal cells travel to other parts of the body and form new tumours. Metastasis refers to the spread of cancer from one area of the body to another.

Prostate treatment and prevention of prostate cancer: Fine Treatment offers the first effective prostate treatment, particularly for BPH and chronic prostatitis which relieves pelvic pain and other symptoms and is the best powerful prevention measure of the development of prostate cancer as these heath conditions are interconnected. You can find video evidences of Dr Allen’s device effectiveness in this article.

London, United Kingdom (PRWEB) August 09, 2011

Dr Simon Allen of Fine Treatment states a common belief that inflammation of a prostate may lead over time to the development of prostate cancer. Despite some doctors’ saying that there is no correlation between chronic prostatitis and prostate cancer nobody can argue that infections and inflammations may represent one mechanism through which prostate cancer develops. It’s well known that chronic inflammation of several other organs is associated with various cancers.

For example, the inflammation of the lower esophagus (Barrett’s esophagitis) can lead to esophageal cancer or ulcerative colitis can develop into colon cancer. Since chronic inflammation causes cancer in other organs, it is reasonable to suggest that chronic prostatitis if left unattended may ultimately lead to prostate cancer.

Therefore, it is big news when there is an option of treating chronic prostatitis at home for the first time in the World effectively and thus to prevent the development of prostate cancer.

The second great news is that this prostate treatmentdoes not require antibiotics, medication and/or other operations. Dr Allen’s Device for Prostate Care is beneficial for chronic prostatitis, including CPPS and free from adverse side effects.

Other risks factors of prostate cancer development which can be found in books are aging or changes in male hormones due to aging and are so general that makes preventative measures unsubstantiated.

Fine Treatment avoids a common mistake investigators make and when they fail to mention that prostate cancer is always found together with prostatitis and all men will probably get both diseases if they live long enough. Both prostate cancer and prostatitis raise Prostate Specific Antigen (PSA) levels and both conditions are currently at epidemic levels and, also, Zinc levels are low or absent in both prostate cancer and chronic prostatitis. These facts need to be considered carefully when the prevention measures of prostate cancer are discussed and, indeed, these facts confirm the uniqueness of a natural prostate treatment invented by Dr Allen as a prevention measure of prostate cancer.

According to Dr Allen & Fine Treatment, opinions differ and are controversial about the relationship between Benign Prostatic Hyperplasia (BPH) and prostate cancer. Despite the fact that some of the symptoms of these two conditions are the same, the claim that BPH appears to be etiologically unrelated to prostate cancer has been popular for many years. It is a relief to hear that now this claim has been deemed doubtful. Researchers are beginning to see pathological and genetic links between these two conditions. Furthermore, there are strong suggestions that prostatic inflammation is involved in the pathogenesis and progression of both conditions, it means that chronic prostatitis and BPH and prostate cancer are interconnected.

These new approaches in understanding of prostate cancer development underline the importance of prostate treatment, particularly BPH treatmentand prostatitiscure for prevention of prostate cancer development.

“You have to keep your prostate in healthy condition to avoid prostate cancer in future” says Dr Allen, “Fine Treatment offers the best prostate care option as it is very effective and natural and thus free from adverse side effects.”

For further information, please contact Fine Treatment: http://www.finetreatment.co.uk

For more information and to submit your abstract for the ESMO 14th World Congress on Gastrointestinal Cancer on 27-30 June 2012 please contact us: Submit your abstract online at http://owpm.net/abstracts/WGI/, register for the event online at http://www.worldgicancer.com, e-mail us at registration(at)imedex(dot)com or call us at 1-512-583-8385. Imedex, LLC Presents: ESMO 14th World Congress on Gastrointestinal Cancer occurring on 27-30 June 2012 in Barcelona, Spain. The Scientific Organizing Committee would like to invite all participants to submit their gastrointestinal cancer abstracts for this gastrointestinal oncology continuing medical education event.

Alpharetta, GA (PRWEB) December 27, 2011

Imedex, LLC Presents: ESMO 14th World Congress on Gastrointestinal Cancer occurring on 27-30 June 2012 in Barcelona, Spain. The Scientific Organizing Committee would like to invite all participants to submit their gastrointestinal cancer abstracts for this gastrointestinal oncology continuing medical education event. All approved abstracts will be published in a supplement of the Annals of Oncology and scheduled for oral or poster presentation.

Gastrointestinal cancer abstracts will be accepted in the following categories:

Colon Cancer
Esophageal Cancer
Liver Cancer
Pancreatic Cancer
Rectal Cancer
Other
Guidelines for the abstract submission are as follows:

Abstracts must be written in English;
The submitted work must not, nor will have been published in any journal, or on any web site before 27 June 2012, nor presented at any national or international scientific conference prior to 27 June 2012;
Accepted format: Word document format, 9 point Arial font, 500 word count limit;
Use a concise title;
List affiliations of author(s) as briefly as possible, with city, province and country;
Use standard and well-accepted abbreviations;
When using references, use standard and well-accepted formats;
Abstract content should be single-spaced and typed in lower case;
Abstracts shall be of original research and contain a concise statement of study aim;
Please include and indicate in bold the following four (4) parts of your abstract: Background, Method, Results, and Conclusion(s);
Conclusions must be supported by your results and summarized within your abstract at the time of submission. Results “to be completed” and/or conclusions “to be discussed” are not acceptable.
Please note that a limited number of travel awards are available for investigators from developing nations. Awards are available to investigators from the countries indicated in the 2011 World Bank List of Economies as Low-Income or Lower Middle Income Economies. The complete list can be found at web.worldbank.org.
These awards will consist of Congress registration and a grant in the amount of €1500 to cover airfare and hotel, given to the recipient at the Congress. Airfare can be purchased by Imedex and deducted from this amount, if needed. If you have questions about this information, please contact Imedex.

You can apply for Developing Nations Travel Awards by completing the following requirements:

The candidate must submit an abstract to the ESMO 14th World Congress on Gastrointestinal Cancer in the usual manner, indicating that the abstract is to be considered for the Developing Nations Award
The candidate must be the first author of the submitted abstract
The work must not have been presented or published before the date of the ESMO 14th World Congress on Gastrointestinal Cancer
Abstracts must be submitted on schedule
Candidates should submit:
An extended abstract
A Curriculum Vitae
A 1-3 page description of their interests and current research in gastrointestinal cancer signed and approved by their department chair
The Educational Committee will select the award winners on the basis of the scientific content of the abstract. Winners will be notified in April 2012.

Important Abstract Dates:

Abstract Submission Deadline – 12 March, 2012
Abstract Notifications Mailed – 16 April, 2012
Abstract Presenter Registration Deadline – 3 May, 2012
Presentation Deadlines – 27-30 June, 2012

The ESMO World Congress on Gastrointestinal Cancer is the world’s leading forum for practicing clinicians and specialists in cancer research to participate in the allocation of the newest information and review state of the art information on the management of gastrointestinal cancer. Over 60 expert specialists will lead sessions and meet with participants in small targeted groups to address their educational needs.

Among the specialists will be Nadir Arber, MD, MSc, MHA, Andrés Cervantes, MD, PhD, Fortunato Ciardiello, MD, PhD, Mario Dicato, MD, Bengt Glimelius, MD, PhD, Richard M. Goldberg, MD, Axel Grothey, MD, Karin Haustermans, MD, PhD, Yoon-Koo Kang, MD, PhD, David J. Kerr, MD, FRCP, Roberto Labianca, MD, John L. Marshall, MD, Bernard Nordlinger, MD, Arnaud D. Roth, MD, Philippe Rougier, MD, PhD, Wolff Schmiegel, MD,PhD, Josep Tabernero, MD, PhD, Eric Van Cutsem, MD, PhD, Cornelius J.H. van de Velde, MD, PhD and John R. Zalcberg, MD, PhD.

The World Congress will focus on personalized therapy, multidisciplinary management and unraveling molecular mechanisms, and will educate and update a broad range of experts. This target audience will include practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers. Cutting-edge research will be a key feature in this continuing medical education conference giving researchers worldwide the ability to interact with colleagues and share their educational endeavors. Participants are invited to submit their abstracts to be considered for presentation.

This live gastroenterology CME webinar will be held on 27-30 June 2012.

For more information and to submit your abstract for the ESMO 14th World Congress on Gastrointestinal Cancer on 27-30 June 2012 please contact us:

Submit your abstract online

Register for the event online at http://www.worldgicancer.com
E-mail us at registration(at)imedex(dot)com
or
Call us at 1-512-583-8385

For event updates, and more information on this exciting oncology-cme event and to connect with us! Find us on:

Facebook at http://www.facebook.com/pages/World-Congress-on-Gastrointestinal-Cancer/238342882879815?sk=wall

Twitter @GICancercongres

About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.

Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex truly educates the global healthcare community. At Imedex, we believe that education is the best medicine.®

For more Imedex events and updates visit our blog at http://oncologycme.tumblr.com or go to http://www.imedex.com.

Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email us at growyourbusiness(at)audiencegeneration(dot)com or visit us at: http://www.audiencegeneration.com.

There are a lot of different treatments that people can choose to undergo in an effort fight their cancers, and a lot of these have had good rates of success so a Cancer victims don’t have to give up hope.